U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. PDUFA Pilot Project: Proprietary Name Review - Concept Paper
  1. Search for FDA Guidance Documents

CONCEPT PAPER

PDUFA Pilot Project: Proprietary Name Review - Concept Paper October 2008

Download the Final Concept Paper Read the Federal Register Notice
Final
Docket Number:
FDA-2008-N-0281
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

On September 27, 2007, President Bush signed into law the Food and Drug Administration Amendments Act of 2007 (Pub. L. 110-85, 121 Stat. 823 (FDAAA), which includes the reauthorization and expansion of the Prescription Drug User Fee Act (PDUFA IV).

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2008-N-0281.

Back to Top